Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 1
1983 1
1984 2
1985 2
1986 2
1988 4
1989 3
1990 8
1991 1
1992 7
1993 4
1994 4
1995 6
1996 5
1997 9
1998 9
1999 12
2000 18
2001 25
2002 39
2003 45
2004 57
2005 81
2006 90
2007 99
2008 100
2009 121
2010 186
2011 178
2012 186
2013 263
2014 315
2015 312
2016 340
2017 400
2018 445
2019 536
2020 617
2021 687
2022 899
2023 907
2024 297

Text availability

Article attribute

Article type

Publication date

Search Results

6,543 results

Results by year

Filters applied: . Clear all
Page 1
Whole-brain spatial organization of hippocampal single-neuron projectomes.
Qiu S, Hu Y, Huang Y, Gao T, Wang X, Wang D, Ren B, Shi X, Chen Y, Wang X, Wang D, Han L, Liang Y, Liu D, Liu Q, Deng L, Chen Z, Zhan L, Chen T, Huang Y, Wu Q, Xie T, Qian L, Jin C, Huang J, Deng W, Jiang T, Li X, Jia X, Yuan J, Li A, Yan J, Xu N, Xu L, Luo Q, Poo MM, Sun Y, Li CT, Yao H, Gong H, Sun YG, Xu C. Qiu S, et al. Among authors: luo q. Science. 2024 Feb 2;383(6682):eadj9198. doi: 10.1126/science.adj9198. Epub 2024 Feb 2. Science. 2024. PMID: 38300992
The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation.
Luo F, Li H, Ma W, Cao J, Chen Q, Lu F, Qiu M, Zhou P, Xia Z, Zeng K, Zhan J, Zhou T, Luo Q, Pan W, Zhang L, Lin C, Huang Y, Zhang L, Yang D, Zhao H. Luo F, et al. Among authors: luo q. Cell Mol Immunol. 2024 Jan;21(1):60-79. doi: 10.1038/s41423-023-01112-y. Epub 2023 Dec 7. Cell Mol Immunol. 2024. PMID: 38062129 Free PMC article.
Stimuli-activatable nanomedicine meets cancer theranostics.
Li H, Feng Y, Luo Q, Li Z, Li X, Gan H, Gu Z, Gong Q, Luo K. Li H, et al. Among authors: luo q. Theranostics. 2023 Oct 2;13(15):5386-5417. doi: 10.7150/thno.87854. eCollection 2023. Theranostics. 2023. PMID: 37908735 Free PMC article. Review.
Dynamic immuno-nanomedicines in oncology.
Ling H, Zhang Q, Luo Q, Ouyang D, He Z, Sun J, Sun M. Ling H, et al. Among authors: luo q. J Control Release. 2024 Jan;365:668-687. doi: 10.1016/j.jconrel.2023.11.052. Epub 2023 Dec 7. J Control Release. 2024. PMID: 38042376 Review.
Anti-breast cancer-induced cardiomyopathy: Mechanisms and future directions.
Liu C, Chen H, Guo S, Liu Q, Chen Z, Huang H, Zhao Q, Li L, Cen H, Jiang Z, Luo Q, Chen X, Zhao J, Chen W, Yang PC, Wang L. Liu C, et al. Among authors: luo q. Biomed Pharmacother. 2023 Oct;166:115373. doi: 10.1016/j.biopha.2023.115373. Epub 2023 Aug 28. Biomed Pharmacother. 2023. PMID: 37647693 Free article. Review.
6,543 results